Literature DB >> 18278194

Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.

Manuel Zürcher1, Irmela Sulzer, Gabriela Barizzi, Bernhard Lämmle, Lorenzo Alberio.   

Abstract

Many preanalytical variables affect the results of coagulation assays. A possible way to control some of them would be to accept blood specimens shipped in the original collection tube. The aim of our study was to investigate the stability of coagulation assays in citrated whole blood transported at ambient temperature for up to two days after specimen collection. Blood samples from 59 patients who attended our haematology outpatient ward for thrombophilia screening were transported at ambient temperature (outdoor during the day, indoor overnight) for following periods of time: <1 hour, 4-6, 8-12, 24-28 and 48-52 hours prior to centrifugation and plasma-freezing. The following coagulation tests were performed: PT, aPTT, fibrinogen, FII:C, FV:C, FVII:C, FVIII:C, FIX:C, FX:C, FXI:C, VWF:RCo, VWF:Ag, AT, PC activity, total and free PS antigen, modified APC-sensitivity-ratio, thrombin-antithrombin-complex and D-dimer. Clinically significant changes, defined as a percentage change of more than 10% from the initial value, were observed for FV:C, FVIII:C and total PS antigen starting at 24-28 hours, and for PT, aPTT and FVII:C at 48-52 hours. No statistically significant differences were seen for fibrinogen, antithrombin, or thrombin-antithrombin complexes (Friedman repeated measures analysis of variance). The present data suggest that the use of whole blood samples transported at ambient temperature may be an acceptable means of delivering specimens for coagulation analysis. With the exception of factor V and VIII coagulant activity, and total PS antigen all investigated parameters can be measured 24-28 hours after specimen collection without observing clinically relevant changes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278194     DOI: 10.1160/TH07-07-0448

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Clotting factor deficiency in early trauma-associated coagulopathy.

Authors:  Sandro B Rizoli; Sandro Scarpelini; Jeannie Callum; Bartolomeu Nascimento; Kenneth G Mann; Ruxandra Pinto; Jan Jansen; Homer C Tien
Journal:  J Trauma       Date:  2011-11

2.  Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery.

Authors:  Dino Kröll; Guido Stirnimann; Andreas Vogt; Desirée Lin Lee Lai; Yves Michael Borbély; Julia Altmeier; Sabine Schädelin; Daniel Candinas; Lorenzo Alberio; Philipp C Nett
Journal:  Br J Clin Pharmacol       Date:  2017-03-09       Impact factor: 4.335

3.  Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).

Authors:  Marie Méan; Drahomir Aujesky; Bernhard Lämmle; Christiane Gerschheimer; Sven Trelle; Anne Angelillo-Scherrer
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

4.  Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data.

Authors:  Manuel Burggraf; Arzu Payas; Max Daniel Kauther; Carsten Schoeneberg; Sven Lendemans
Journal:  World J Emerg Surg       Date:  2015-09-22       Impact factor: 5.469

Review 5.  Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories.

Authors:  A Magnette; M Chatelain; B Chatelain; H Ten Cate; F Mullier
Journal:  Thromb J       Date:  2016-12-12

6.  Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.

Authors:  Elettra C Poli; Lorenzo Alberio; Anna Bauer-Doerries; Carlo Marcucci; Aurélien Roumy; Matthias Kirsch; Eleonora De Stefano; Lucas Liaudet; Antoine G Schneider
Journal:  Crit Care       Date:  2019-04-03       Impact factor: 9.097

7.  Haemostatic Changes in Five Patients Infected with Ebola Virus.

Authors:  Sophie J Smither; Lyn M O'Brien; Lyn Eastaugh; Tom Woolley; Steve Lever; Tom Fletcher; Kiran Parmar; Beverley J Hunt; Sarah Watts; Emrys Kirkman
Journal:  Viruses       Date:  2019-07-15       Impact factor: 5.048

8.  Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders.

Authors:  Marcel Adler; Jonas Kaufmann; Lorenzo Alberio; Michael Nagler
Journal:  J Thromb Haemost       Date:  2019-05-22       Impact factor: 5.824

9.  Effects of storage time and temperature on coagulation tests and factors in fresh plasma.

Authors:  Limin Feng; Ying Zhao; Hongcan Zhao; Zhexin Shao
Journal:  Sci Rep       Date:  2014-01-27       Impact factor: 4.379

10.  Trauma induced clotting factor depletion in severely injured children: a single center observational study.

Authors:  Manuel Burggraf; Christina Polan; Martin Husen; Bastian Mester; Alexander Wegner; Daniel Spodeck; Marcel Dudda; Max Daniel Kauther
Journal:  World J Emerg Surg       Date:  2020-05-06       Impact factor: 5.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.